Masimo Retained Earnings (Accumulated Deficit) 2010-2025 | MASI
Masimo retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Masimo retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $1.320B, a 27.25% decline year-over-year.
- Masimo retained earnings (accumulated deficit) for 2024 were $1.491B, a 16.98% decline from 2023.
- Masimo retained earnings (accumulated deficit) for 2023 were $1.796B, a 4.75% increase from 2022.
- Masimo retained earnings (accumulated deficit) for 2022 were $1.714B, a 9.14% increase from 2021.
| Masimo Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $1,491 |
| 2023 | $1,796 |
| 2022 | $1,714 |
| 2021 | $1,571 |
| 2020 | $1,341 |
| 2019 | $1,100 |
| 2018 | $931 |
| 2017 | $738 |
| 2016 | $589 |
| 2015 | $289 |
| 2014 | $205 |
| 2013 | $133 |
| 2012 | $74 |
| 2011 | $69 |
| 2010 | $6 |
| 2009 | $94 |
| Masimo Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,320 |
| 2024-12-31 | $1,491 |
| 2024-09-30 | $1,841 |
| 2024-06-30 | $1,831 |
| 2024-03-31 | $1,815 |
| 2023-12-31 | $1,796 |
| 2023-09-30 | $1,762 |
| 2023-06-30 | $1,751 |
| 2023-03-31 | $1,736 |
| 2022-12-31 | $1,714 |
| 2022-09-30 | $1,674 |
| 2022-06-30 | $1,636 |
| 2022-03-31 | $1,617 |
| 2021-12-31 | $1,571 |
| 2021-09-30 | $1,503 |
| 2021-06-30 | $1,445 |
| 2021-03-31 | $1,395 |
| 2020-12-31 | $1,341 |
| 2020-09-30 | $1,271 |
| 2020-06-30 | $1,221 |
| 2020-03-31 | $1,165 |
| 2019-12-31 | $1,100 |
| 2019-09-30 | $1,048 |
| 2019-06-30 | $998 |
| 2019-03-31 | $954 |
| 2018-12-31 | $931 |
| 2018-09-30 | $884 |
| 2018-06-30 | $827 |
| 2018-03-31 | $783 |
| 2017-12-31 | $738 |
| 2017-09-30 | $720 |
| 2017-06-30 | $681 |
| 2017-03-31 | $635 |
| 2016-12-31 | $589 |
| 2016-09-30 | $374 |
| 2016-06-30 | $346 |
| 2016-03-31 | $316 |
| 2015-12-31 | $289 |
| 2015-09-30 | $264 |
| 2015-06-30 | $245 |
| 2015-03-31 | $226 |
| 2014-12-31 | $205 |
| 2014-09-30 | $184 |
| 2014-06-30 | $169 |
| 2014-03-31 | $155 |
| 2013-12-31 | $133 |
| 2013-09-30 | $123 |
| 2013-06-30 | $108 |
| 2013-03-31 | $91 |
| 2012-12-31 | $74 |
| 2012-09-30 | $117 |
| 2012-06-30 | $103 |
| 2012-03-31 | $85 |
| 2011-12-31 | $69 |
| 2011-09-30 | $56 |
| 2011-06-30 | $41 |
| 2011-03-31 | $24 |
| 2010-12-31 | $6 |
| 2010-09-30 | $34 |
| 2010-06-30 | $18 |
| 2010-03-31 | $3 |
| 2009-12-31 | $94 |
| 2009-09-30 | $80 |
| 2009-06-30 | $67 |
| 2009-03-31 | $54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.811B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.969B | 86.71 |
| Thermo Fisher Scientific (TMO) | United States | $152.062B | 18.39 |
| Edwards Lifesciences (EW) | United States | $45.884B | 30.08 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $41.285B | 47.44 |
| DexCom (DXCM) | United States | $33.643B | 52.00 |
| IQVIA Holdings (IQV) | United States | $24.277B | 13.60 |
| STERIS (STE) | Ireland | $24.122B | 26.57 |
| Mettler-Toledo (MTD) | United States | $24.015B | 28.56 |
| Waters (WAT) | United States | $20.783B | 29.32 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.675B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $10.339B | 81.15 |
| Globus Medical (GMED) | United States | $8.012B | 19.09 |
| Teleflex (TFX) | United States | $5.403B | 8.92 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| TransMedics (TMDX) | United States | $4.300B | 93.47 |
| Integer Holdings (ITGR) | United States | $4.144B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.358B | 14.04 |
| Veracyte (VCYT) | United States | $2.084B | 29.24 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.996B | 17.94 |
| Alphatec Holdings (ATEC) | United States | $1.817B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.320B | 0.00 |
| Artivion (AORT) | United States | $1.263B | 118.32 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.747B | 0.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.34 |
| RxSight (RXST) | United States | $0.621B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.581B | 9.04 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 11.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.414B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.289B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| 908 Devices (MASS) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.153B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.60 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |